{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:37:11Z","timestamp":1790185031136,"version":"4.1.0"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T00:00:00Z","timestamp":1575936000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.ctro.2019.12.001","type":"journal-article","created":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T03:08:09Z","timestamp":1576033689000},"page":"32-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Treatment of oligometastatic lung cancer with brain metastases using stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT)"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1101-7233","authenticated-orcid":false,"given":"John","family":"Nikitas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6954-3730","authenticated-orcid":false,"given":"Michael","family":"Roach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1399-9904","authenticated-orcid":false,"given":"Cliff","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Perkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Tsien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ctro.2019.12.001_b0005","first-page":"7","article-title":"Cancer Statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.ctro.2019.12.001_b0010","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3892\/mco.2014.410","article-title":"Specific organ metastases and survival in metastatic non-small-cell lung cancer","volume":"3","author":"Tamura","year":"2015","journal-title":"Mol Clin Oncol"},{"issue":"8","key":"10.1016\/j.ctro.2019.12.001_b0015","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1200\/JOP.2016.012922","article-title":"Stereotactic radiosurgery for treatment of brain metastases","volume":"12","author":"Badiyan","year":"2016","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.ctro.2019.12.001_b0020","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae). Non-small cell lung cancer [Internet]. Dec 2018 [cited 2019 Mar 31]; version 2.2018: [211 p.]. Available from: https:\/\/www2.tri-kobe.org\/nccn\/guideline\/lung\/english\/non_small.pdf."},{"issue":"2","key":"10.1016\/j.ctro.2019.12.001_b0025","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cllc.2018.10.010","article-title":"Stereotactic body radiotherapy for early-stage multiple primary lung cancers","volume":"20","author":"Nikitas","year":"2019","journal-title":"Clin Lung Cancer"},{"issue":"2","key":"10.1016\/j.ctro.2019.12.001_b0030","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/j.ijrobp.2016.06.035","article-title":"Efficacy and Toxicity Analysis of NRG Oncology\/RTOG 0813 Trial of Stereotactic Body Radiation Therapy (SBRT) for Centrally Located Non-Small Cell Lung Cancer (NSCLC)","volume":"96","author":"Bezjak","year":"2016","journal-title":"Int J Radiat Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2019.12.001_b0035","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/j.ijrobp.2007.07.156","article-title":"Toxicity analysis of RTOG 0236 using stereotactic body radiation therapy to treat medically inoperable early stage lung cancer patients","volume":"69","author":"Timmerman","year":"2017","journal-title":"Int J Radiat Oncol"},{"issue":"2","key":"10.1016\/j.ctro.2019.12.001_b0040","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.adro.2017.11.003","article-title":"Internal dose escalation is associated with increased local control for non-small cell lung cancer (NSCLC) brain metastases treated with stereotactic radiosurgery (SRS)","volume":"3","author":"Abraham","year":"2018","journal-title":"Adv Radiat Oncol"},{"issue":"2","key":"10.1016\/j.ctro.2019.12.001_b0045","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0360-3016(99)00507-6","article-title":"Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90\u201305","volume":"47","author":"Shaw","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"10.1016\/j.ctro.2019.12.001_b0050","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1002\/cncr.23357","article-title":"Pulmonary resection in patients with nonsmall-cell lung cancer treated with gamma-knife radiosurgery for synchronous brain metastases","volume":"112","author":"Yang","year":"2008","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.ctro.2019.12.001_b0055","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/cncr.21818","article-title":"Nonsmall cell lung cancer presenting with synchronous solitary brain metastasis","volume":"106","author":"Hu","year":"2006","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ctro.2019.12.001_b0060","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijrobp.2007.12.031","article-title":"Long-term survival in patients with synchronous, solitary brain metastasis from non-small-cell lung cancer treated with radiosurgery","volume":"72","author":"Flannery","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ctro.2019.12.001_b0065","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.lungcan.2014.06.001","article-title":"Aggressive therapy for patients with non-small cell lung carcinoma and synchronous brain-only oligometastatic disease is associated with long-term survival","volume":"85","author":"Gray","year":"2014","journal-title":"Lung Cancer"},{"issue":"3","key":"10.1016\/j.ctro.2019.12.001_b0070","first-page":"186","article-title":"Surgical management of primary non-small-cell carcinoma of lung with synchronous solitary brain metastasis: local experience","volume":"16","author":"Lo","year":"2010","journal-title":"Hong Kong Med J"},{"issue":"12","key":"10.1016\/j.ctro.2019.12.001_b0075","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S1470-2045(16)30532-0","article-title":"Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study","volume":"17","author":"Gomez","year":"2016","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2019.12.001_b0080","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2017.3501","article-title":"Consolidative radiotherapy for limited metastatic non-small-cell lung cancer: A phase 2 randomized clinical trial","volume":"4","author":"Iyengar","year":"2018","journal-title":"JAMA Oncol"},{"issue":"10185","key":"10.1016\/j.ctro.2019.12.001_b0085","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial","volume":"393","author":"Palma","year":"2019","journal-title":"Lancet"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630819301144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630819301144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:07:28Z","timestamp":1762502848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630819301144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":17,"alternative-id":["S2405630819301144"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2019.12.001","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of oligometastatic lung cancer with brain metastases using stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT)","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2019.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}]}}